Annual CFO
-$29.55 M
-$3.65 M-14.10%
31 December 2023
Summary:
eFFECTOR Therapeutics annual cash flow from operations is currently -$29.55 million, with the most recent change of -$3.65 million (-14.10%) on 31 December 2023. During the last 3 years, it has fallen by -$4.66 million (-18.73%). EFTR annual CFO is now -313.59% below its all-time high of $13.84 million, reached on 31 December 2020.EFTR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.28 M
-$1.71 M-30.76%
31 March 2024
Summary:
eFFECTOR Therapeutics quarterly cash flow from operations is currently -$7.28 million, with the most recent change of -$1.71 million (-30.76%) on 31 March 2024. Over the past year, it has dropped by -$1.71 million (-30.76%). EFTR quarterly CFO is now -63.99% below its all-time high of -$4.44 million, reached on 30 June 2022.EFTR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$29.19 M
+$359.00 K+1.21%
31 March 2024
Summary:
eFFECTOR Therapeutics TTM cash flow from operations is currently -$29.19 million, with the most recent change of +$359.00 thousand (+1.21%) on 31 March 2024. Over the past year, it has increased by +$359.00 thousand (+1.21%). EFTR TTM CFO is now -484.17% below its all-time high of -$5.00 million, reached on 31 March 2021.EFTR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EFTR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -30.8% | +1.2% |
| 3 y3 years | -18.7% | -45.3% | -17.3% |
| 5 y5 years | - | - | - |
EFTR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.7% | at low | -64.0% | +15.3% | -21.0% | +6.4% |
| 5 y | 5 years | -313.6% | at low | -64.0% | +19.7% | -484.2% | +6.4% |
| alltime | all time | -313.6% | at low | -64.0% | +19.7% | -484.2% | +6.4% |
EFFECTOR Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$7.28 M(+30.8%) | -$29.19 M(-1.2%) |
| Dec 2023 | -$29.55 M(+14.1%) | -$5.57 M(-28.2%) | -$29.55 M(-3.9%) |
| Sept 2023 | - | -$7.75 M(-9.7%) | -$30.76 M(-1.4%) |
| June 2023 | - | -$8.59 M(+12.5%) | -$31.19 M(+15.4%) |
| Mar 2023 | - | -$7.64 M(+12.6%) | -$27.04 M(+4.4%) |
| Dec 2022 | -$25.90 M | -$6.78 M(-17.2%) | -$25.90 M(+7.3%) |
| Sept 2022 | - | -$8.18 M(+84.4%) | -$24.13 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$4.44 M(-31.7%) | -$25.01 M(-5.2%) |
| Mar 2022 | - | -$6.50 M(+29.7%) | -$26.39 M(+6.0%) |
| Dec 2021 | -$24.89 M(-279.9%) | -$5.01 M(-44.8%) | -$24.89 M(+25.2%) |
| Sept 2021 | - | -$9.07 M(+55.9%) | -$19.88 M(+83.9%) |
| June 2021 | - | -$5.82 M(+16.4%) | -$10.81 M(+116.4%) |
| Mar 2021 | - | -$5.00 M | -$5.00 M |
| Dec 2020 | $13.84 M | - | - |
FAQ
- What is eFFECTOR Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly CFO year-on-year change?
- What is eFFECTOR Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM CFO year-on-year change?
What is eFFECTOR Therapeutics annual cash flow from operations?
The current annual CFO of EFTR is -$29.55 M
What is the all time high annual CFO for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual cash flow from operations is $13.84 M
What is eFFECTOR Therapeutics quarterly cash flow from operations?
The current quarterly CFO of EFTR is -$7.28 M
What is the all time high quarterly CFO for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly cash flow from operations is -$4.44 M
What is eFFECTOR Therapeutics quarterly CFO year-on-year change?
Over the past year, EFTR quarterly cash flow from operations has changed by -$1.71 M (-30.76%)
What is eFFECTOR Therapeutics TTM cash flow from operations?
The current TTM CFO of EFTR is -$29.19 M
What is the all time high TTM CFO for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM cash flow from operations is -$5.00 M
What is eFFECTOR Therapeutics TTM CFO year-on-year change?
Over the past year, EFTR TTM cash flow from operations has changed by +$359.00 K (+1.21%)